Kindred Biosciences' Fourth Quarter 2017 Financial Results (Live)
03/01/18 at 4:30 p.m. ET
KindredBio is a biotechnology company that develops medicines for pets. We believe that our animal family members deserve the same great medicines that human family members enjoy.
Stock InformationNASDAQ CM$8.55
Kindred Biosciences to Announce Fourth Quarter and Year-End 2017 Financial Results
February 15, 2018
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
Kindred Biosciences to Participate in the Bank of America Merrill Lynch Animal Health Summit
February 13, 2018
SAN FRANCISCO, Feb. 13, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
KindredBio Announces Submission of European Medicines Agency Filing for Mirataz™
December 21, 2017
SAN FRANCISCO, Dec. 21, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...